GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing SL Pharmaceutical Co Ltd (SZSE:002038) » Definitions » Construction In Progress

Beijing SL Pharmaceutical Co (SZSE:002038) Construction In Progress : ¥83.3 Mil (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Beijing SL Pharmaceutical Co Construction In Progress?

Beijing SL Pharmaceutical Co's quarterly construction in progress increased from Mar. 2024 (¥60.2 Mil) to Jun. 2024 (¥65.4 Mil) and increased from Jun. 2024 (¥65.4 Mil) to Sep. 2024 (¥83.3 Mil).

Beijing SL Pharmaceutical Co's annual construction in progress declined from Dec. 2021 (¥99.9 Mil) to Dec. 2022 (¥64.7 Mil) and declined from Dec. 2022 (¥64.7 Mil) to Dec. 2023 (¥57.0 Mil).

Beijing SL Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Beijing SL Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing SL Pharmaceutical Co Construction In Progress Chart

Beijing SL Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.16 67.70 99.87 64.75 56.98

Beijing SL Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.10 56.98 60.19 65.44 83.29

Beijing SL Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Beijing SL Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing SL Pharmaceutical Co Ltd (SZSE:002038) » Definitions » Construction In Progress
Comparable Companies
SZSE:000078 SZSE:002390 SZSE:000597 SHSE:601089 SHSE:600195 SZSE:300723 SHSE:600789 SZSE:300725 SZSE:002581 SZSE:002550 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
N/A
Address
No.69 Fu shi Road, No.1 Building, Bitongyuan, Haidian district, Beijing, CHN, 100049
Website
http://www.slpharm.com.cn
Beijing SL Pharmaceutical Co Ltd is a Chinese biotechnology-pharmaceutical company. It is principally focused on developing and marketing gene engineering drugs. The product portfolio of the company includes drugs for Oncology, Hepatopathy and Senile disease. Its products include Filgrastim, Asparaginase, Dasartinib, Enoxaparin, Naftopidil, Ademetionine, Lenalidomide, and others.
Executives
Liang Shu Jie Secretary, Director
Xu Ming Bo Directors, executives
Yang Zhong Fan Supervisors
Chen Yu Lin Director
Qi Yan Ming Supervisors
Xi Wen Ying Executives
Wu Yan Zhuo Executives
Wang Wen Xin Director
Li Ya Jun Executives
Zhao Xia Securities Affairs Representative
Zhang Chun Lei Supervisors
Wang Yong Bo Directors, executives
Lu An Jing Supervisors
Wei Su Yan Director

Beijing SL Pharmaceutical Co Headlines

No Headlines